Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.

Metastatic renal cell carcinoma (RCC) has a poor prognosis. Conventional treatment strategies, including chemotherapy and hormonal therapy, have limited value. Although encouraging results have been achieved in terms of objective response using immunological manipulations, no conclusive studies yet...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksson, R., Nilsson, S., Colleen, S., Wersäll, P., Helsing, M., Zimmerman, R., Engman, K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150170/
https://www.ncbi.nlm.nih.gov/pubmed/9579838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150170/
https://www.ncbi.nlm.nih.gov/pubmed/9579838

Ejemplares similares